A once-daily, oral, hormonal treatment for metastatic, castration-resistant, prostate cancer in men who have previously received docetaxel.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
A once-daily, oral, hormonal treatment for metastatic, castration-resistant, prostate cancer in men who have previously received docetaxel.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Hayes Report Sale Policy: Hayes will review your request to purchase a report and respond to you. Individuals requesting reports due to a payment denial should contact the involved health insurer for details and information.
Please contact us if you are interested in a Hayes subscription.
Learn more about our Privacy Policy
This site uses cookies. By continuing to use this website, you agree to their use. For details, please review our Privacy Policy